Fucosylated Glycosaminoglycan Oligosaccharide HS14, Derived from Sea Cucumbers, Is a Novel Inhibitor of Platelet Toll-like Receptor 2
Marine Drugs · 2025
DOI: 10.3390/md23030110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Huifang Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Blood Platelets, Glycosaminoglycans, Oligosaccharides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Fundamental Research Funds for the Central Universities, South-Central Minzu University.
Abstract (Originalsprache)
(1)
Background
Toll-like receptor 2 (TLR2) on platelets is increasingly recognized as a pivotal mediator in infection-induced platelet activation and aggregation, contributing to both inflammatory and thrombotic diseases. Targeting TLR2 on platelets offers a promising therapeutic strategy for inflammatory and thrombotic-related disorders. However, inhibitors targeting platelet TLR2 have not yet been reported. (2)
Methods
Platelet aggregation was assessed using a light transmission aggregometer. Platelet activation was evaluated by measuring the release of P-selectin and von Willebrand factor (vWF) via ELISA. Intracellular Ca2+ mobilization was quantified using Fluo 3-AM fluorescence, recorded by flow cytometry. Static platelet adhesion was visualized under a microscope, and the formation of platelet–granulocyte aggregates in human whole blood was analyzed by flow cytometry. (3)
Results
Fucosylated glycosaminoglycan (FG) tetradecasaccharide HS14 inhibited the activation and aggregation of human platelets induced by the synthetic bacterial lipopeptide Pam3CSK4 in a concentration-dependent manner. This inhibitory effect gives rise to significant anti-inflammatory and anti-thrombotic activities, as evidenced by reduced platelet adhesion and decreased platelet–granulocyte aggregates formation in human whole blood. (4)
Conclusions
This study is the first to identify FG oligosaccharide HS14 as a promising inhibitor of platelet TLR2/TLR1, demonstrating significant therapeutic potential for inflammatory and thrombotic-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, China.
- College of Life Sciences, South-Central Minzu University, Wuhan 430074, China.
- State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, China.
Förderung
- the National Natural Science Foundation of China
- the Fundamental Research Funds for the Central Universities, South-Central Minzu University
Zitieren
APA
Sun, H., Zhu, G., Li, S., Li, P., Zhang, J., Yin, R., Yuan, L., Gao, N., & Zhao, J. (2025). Fucosylated Glycosaminoglycan Oligosaccharide HS14, Derived from Sea Cucumbers, Is a Novel Inhibitor of Platelet Toll-like Receptor 2. Marine Drugs. https://doi.org/10.3390/md23030110
Vancouver
Sun H, Zhu G, Li S, Li P, Zhang J, Yin R, et al. Fucosylated Glycosaminoglycan Oligosaccharide HS14, Derived from Sea Cucumbers, Is a Novel Inhibitor of Platelet Toll-like Receptor 2. Marine Drugs. 2025. doi:10.3390/md23030110
BibTeX
@article{Sun2025,
author = {Sun, Huifang and Zhu, Guangyu and Li, Sujuan and Li, Pengfei and Zhang, Jiali and Yin, Ronghua and Yuan, Lin and Gao, Na and Zhao, Jinhua},
title = {Fucosylated Glycosaminoglycan Oligosaccharide HS14, Derived from Sea Cucumbers, Is a Novel Inhibitor of Platelet Toll-like Receptor 2},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23030110}
}
EUVIMED